- Home
- NMG vs CERS Comparison
NMG vs CERS Comparison
Compare NMG & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMG
- CERS
- Stock Information
- Founded
- NMG 2011
- CERS 1991
- Country
- NMG Canada
- CERS United States
- Employees
- NMG N/A
- CERS N/A
- Industry
- NMG Other Metals and Minerals
- CERS EDP Services
- Sector
- NMG Basic Materials
- CERS Technology
- Exchange
- NMG Nasdaq
- CERS Nasdaq
- Market Cap
- NMG 297.2M
- CERS 255.0M
- IPO Year
- NMG 2017
- CERS 1997
- Fundamental
- Price
- NMG $2.30
- CERS $1.30
- Analyst Decision
- NMG Strong Buy
- CERS Strong Buy
- Analyst Count
- NMG 2
- CERS 2
- Target Price
- NMG $2.58
- CERS $3.50
- AVG Volume (30 Days)
- NMG 53.7K
- CERS 1.1M
- Earning Date
- NMG 11-13-2025
- CERS 10-29-2025
- Dividend Yield
- NMG N/A
- CERS N/A
- EPS Growth
- NMG N/A
- CERS N/A
- EPS
- NMG N/A
- CERS N/A
- Revenue
- NMG N/A
- CERS $192,510,000.00
- Revenue This Year
- NMG N/A
- CERS $22.02
- Revenue Next Year
- NMG N/A
- CERS $9.32
- P/E Ratio
- NMG N/A
- CERS N/A
- Revenue Growth
- NMG N/A
- CERS 13.25
- 52 Week Low
- NMG $1.22
- CERS $1.12
- 52 Week High
- NMG $2.58
- CERS $2.24
- Technical
- Relative Strength Index (RSI)
- NMG 72.93
- CERS 52.56
- Support Level
- NMG $2.08
- CERS $1.17
- Resistance Level
- NMG $1.97
- CERS $1.27
- Average True Range (ATR)
- NMG 0.08
- CERS 0.06
- MACD
- NMG 0.03
- CERS 0.00
- Stochastic Oscillator
- NMG 94.32
- CERS 72.22
About NMG Nouveau Monde Graphite Inc.
Nouveau Monde Graphite Inc is a mineral exploration company. The company specializes in the exploration, evaluation, and development of mineral properties located in Quebec and is developing a natural graphite-based anode material that would qualify as battery-grade material to supply the lithium-ion industry. The company currently operates in two segments: the Matawinie Mine Project and the Battery Material Plant project.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.